Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Ifngem1/Cya
Common Name:
Ifng-KO
Product ID:
S-KO-02582
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ifng-KO
Strain ID
KOCMP-15978-Ifng-B6N-VA
Gene Name
Ifng
Product ID
S-KO-02582
Gene Alias
IFN-g; If2f; Ifg
Background
C57BL/6NCya
NCBI ID
15978
Modification
Conventional knockout
Chromosome
10
Phenotype
MGI:107656
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Ifngem1/Cya mice (Catalog S-KO-02582) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000068592
NCBI RefSeq
NM_008337
Target Region
Exon 1~4
Size of Effective Region
~4.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Ifng, also known as Interferon gamma, is a cytokine that plays a crucial role in the immune system. It enhances immune function, for example, by promoting the activation of immune cells such as macrophages. It is involved in both innate and adaptive immune responses and is associated with pathways like the JAK-STAT signaling pathway [2].

In autism spectrum disorder (ASD), real-time PCR showed significant up-regulation of IFNG in children with ASD compared to controls, suggesting a functional disruption in the IFNG/IFNG-AS1 regulatory network, which may contribute to the chronic inflammatory aspect of ASD [1]. In colon adenocarcinoma (COAD), IFNG was significantly correlated with tumor immunotherapy biomarkers, and high IFNG expression was associated with longer disease-free survival. Also, autophagy and IFNG were related to cisplatin chemosensitivity, indicating IFNG might be a potential targeted therapy for cisplatin-resistant colon cancer [3]. Polymorphisms in IFNG were associated with tuberculosis in the Tibetan population, with certain alleles acting as protective or risk factors [4,6]. In pancreatic cancer, CDK1/2/5 inhibition can overcome IFNG-mediated adaptive immune resistance, turning a 'cold' tumor microenvironment into a 'hot' one [5]. In atopic dermatitis, high and low IFNG-expressing subgroups were characterized, corresponding to intrinsic and extrinsic AD classifications, which may be considered for evaluating therapeutic efficacy in the future [7].

In conclusion, Ifng is essential in immune-related biological processes. Its dysregulation is implicated in various diseases including ASD, COAD, tuberculosis, pancreatic cancer, and atopic dermatitis. Studies using different research models, though not specifically KO/CKO mouse models in the provided references, have helped to understand its role in these disease conditions, providing insights into potential therapeutic strategies.

References:

1. Fallah, Hamid, Sayad, Arezou, Ranjbaran, Fatemeh, Ghafouri-Fard, Soudeh, Taheri, Mohammad. 2019. IFNG/IFNG-AS1 expression level balance: implications for autism spectrum disorder. In Metabolic brain disease, 35, 327-333. doi:10.1007/s11011-019-00510-4. https://pubmed.ncbi.nlm.nih.gov/31728886/

2. Benci, Joseph L, Johnson, Lexus R, Choa, Ruth, Kambayashi, Taku, Minn, Andy J. . Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. In Cell, 178, 933-948.e14. doi:10.1016/j.cell.2019.07.019. https://pubmed.ncbi.nlm.nih.gov/31398344/

3. Yue, Taohua, Cai, Yunlong, Zhu, Jing, Wang, Pengyuan, Rong, Long. 2023. Autophagy-related IFNG is a prognostic and immunochemotherapeutic biomarker of COAD patients. In Frontiers in immunology, 14, 1064704. doi:10.3389/fimmu.2023.1064704. https://pubmed.ncbi.nlm.nih.gov/36756126/

4. Wu, S-Q, Ding, X-J, Yang, Q-L, Wang, M-G, He, J-Q. . IFNG and IFNGR1 polymorphisms are associated with tuberculosis: a case-control study. In European review for medical and pharmacological sciences, 26, 8777-8787. doi:10.26355/eurrev_202212_30549. https://pubmed.ncbi.nlm.nih.gov/36524496/

5. Huang, Jin, Chen, Pan, Liu, Ke, Kang, Rui, Tang, Daolin. 2020. CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer. In Gut, 70, 890-899. doi:10.1136/gutjnl-2019-320441. https://pubmed.ncbi.nlm.nih.gov/32816920/

6. Wu, Shouquan, Wang, Yu, Zhang, Miaomiao, Wang, Minggui, He, Jian-Qing. 2019. Genetic variants in IFNG and IFNGR1 and tuberculosis susceptibility. In Cytokine, 123, 154775. doi:10.1016/j.cyto.2019.154775. https://pubmed.ncbi.nlm.nih.gov/31310896/

7. Wasserer, Sophia, Jargosch, Manja, Mayer, Kristine E, Eyerich, Kilian, Lauffer, Felix. 2024. Characterization of High and Low IFNG-Expressing Subgroups in Atopic Dermatitis. In International journal of molecular sciences, 25, . doi:10.3390/ijms25116158. https://pubmed.ncbi.nlm.nih.gov/38892346/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest